These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

991 related items for PubMed ID: 24591332

  • 21. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [Abstract] [Full Text] [Related]

  • 22. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015 Jul; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 23. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.
    Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP.
    Hypertension; 2013 Feb; 61(2):457-64. PubMed ID: 23172929
    [Abstract] [Full Text] [Related]

  • 24. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
    Kario K, Bhatt DL, Brar S, Cohen SA, Fahy M, Bakris GL.
    Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
    [Abstract] [Full Text] [Related]

  • 25. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
    Rosa J, Widimský P, Waldauf P, Lambert L, Zelinka T, Táborský M, Branny M, Toušek P, Petrák O, Čurila K, Bednář F, Holaj R, Štrauch B, Václavík J, Nykl I, Krátká Z, Kociánová E, Jiravský O, Rappová G, Indra T, Widimský J.
    Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818
    [Abstract] [Full Text] [Related]

  • 26. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial.
    Warchol-Celinska E, Prejbisz A, Kadziela J, Florczak E, Januszewicz M, Michalowska I, Dobrowolski P, Kabat M, Sliwinski P, Klisiewicz A, Topor-Madry R, Narkiewicz K, Somers VK, Sobotka PA, Witkowski A, Januszewicz A.
    Hypertension; 2018 Aug; 72(2):381-390. PubMed ID: 29941516
    [Abstract] [Full Text] [Related]

  • 27. Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension.
    Ott C, Kopp C, Dahlmann A, Schmid A, Linz P, Cavallaro A, Hammon M, Ditting T, Veelken R, Uder M, Titze J, Schmieder RE.
    Clin Res Cardiol; 2018 Jan; 107(1):42-48. PubMed ID: 28845508
    [Abstract] [Full Text] [Related]

  • 28. The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials.
    Yao Y, Zhang D, Qian J, Deng S, Huang Y, Huang J.
    Clin Exp Hypertens; 2016 Jan; 38(3):278-86. PubMed ID: 27018652
    [Abstract] [Full Text] [Related]

  • 29. Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in patients with resistant hypertension to improve patients' adherence.
    Kjeldsen SE, Fadl Elmula FE, Os I, Persu A, Jin Y, Staessen JA.
    Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):48-56. PubMed ID: 27533966
    [Abstract] [Full Text] [Related]

  • 30. Vascular and renal hemodynamic changes after renal denervation.
    Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677
    [Abstract] [Full Text] [Related]

  • 31. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, Schmieder RE.
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [Abstract] [Full Text] [Related]

  • 32. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K, Rommel KP, Lapusca R, Blazek S, Besler C, Hartung P, von Roeder M, Kresoja KP, Desch S, Thiele H, Lurz P.
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [Abstract] [Full Text] [Related]

  • 35. Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.
    Böhm M, Tsioufis K, Kandzari DE, Kario K, Weber MA, Schmieder RE, Townsend RR, Kulenthiran S, Ukena C, Pocock S, Ewen S, Weil J, Fahy M, Mahfoud F.
    J Am Coll Cardiol; 2021 Sep 07; 78(10):1028-1038. PubMed ID: 34474735
    [Abstract] [Full Text] [Related]

  • 36. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar 07; 30(1-2):207-20. PubMed ID: 23077975
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.
    Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, Wang Y, Saxena M, Lurz P, Sayer J, Bloch MJ, Basile J, Weber MA, Rump LC, Levy T, Sapoval M, Sanghvi K, Rader F, Fisher NDL, Gosse P, Abraham J, Claude L, Barman NC, McClure CK, Liu Y, Kirtane AJ, RADIANCE-HTN Investigators.
    JACC Cardiovasc Interv; 2020 Dec 28; 13(24):2922-2933. PubMed ID: 33357531
    [Abstract] [Full Text] [Related]

  • 39. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, SYMPLICITY HTN-3 Investigators.
    J Am Coll Cardiol; 2014 Sep 16; 64(11):1071-8. PubMed ID: 24858423
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.